Technological innovation stands as a significant driver propelling the next-generation sequencing (NGS) market growth, with continuous advancements in sequencing platforms, such as whole genome ...

Next-generation sequencing (NGS) has increased the speed, scale, throughput, and accessibility of sequencing, greatly accelerating genomic research. This progress has been aided by the development of ...

Generating high-quality next-generation sequencing (NGS) data depends on more than sequencing alone. Sample collection, nucleic acid extraction, fragmentation, library preparation, and quality control ...

Explore how whole exome sequencing works, how capture design determines what is actually covered, and when whole genome sequencing is the better choice.

The landscape of next-generation sequencing (NGS) continues to be defined by astonishing technological progress. We continue to witness sequencer throughput expansion with systems like the Illumina ...

The US Food and Drug Administration (FDA) has released draft guidance on how sponsors can utilize next-generation sequencing (NGS) methods in nonclinical studies to assess the safety risks associated ...

In this free webinar, learn how next-generation sequencing (NGS) can support total potency assurance for adeno-associated virus therapies. The featured speaker will discuss how NGS-based testing can ...

Bulk harvest release testing for adventitious viruses is an integral part of biosafety for manufacturing biopharma products. Finding a testing strategy that works for diverse biologics modalities ...

Pattern of resistance on first-line EGFR-directed therapy in EGFR-positive metastatic non-small cell lung cancer. Utilizing TP53 mutation status and initial disease burden at presentation to ...